Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.735 USD | +0.29% | -11.48% | -42.36% |
05-10 | Ocuphire Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bearish | Bearish |
Resistance | 2.010 | 2.230 | 2.630 |
Spread/Res. | -13.68% | -22.20% | -34.03% |
Spread/Supp. | +14.90% | +14.90% | +7.76% |
Support | 1.510 | 1.510 | 1.610 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- OCUP Stock
- Charts Ocuphire Pharma, Inc.